3 completed, 2 unknown, 1 terminated. 6 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Unknown 2, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Chronic Leukemia: new trials by email Literature Review of Chronic Leukemia trials Research Report on Chronic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nonmyeloablative Haploidentical Transplant Followed by MLN9708 MLN9708 - Acute Leukemia, Chronic Leukemia | Phase 2 | Completed | Northside Hospital, Inc. | 29 | 2014-07-15 | 2021-09-02 |
| Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells Ex vivo expanded cord blood cells - Acute Leukemia, Chronic Leukemia | Phase 1 / Phase 2 | Terminated | Singapore General Hospital | 3 | 2012-03-01 | 2015-11-30 |
| Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation Fludarabine - Acute Leukemia, Chronic Leukemia | Phase 2 | Unknown | Seoul National University Hospital | 46 | 2011-10-01 | 2014-08-20 |
| Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases Peripheral Blood Stem Cell Transplant - Chronic Leukemia, Acute Leukemia | Phase 2 | Completed | Northside Hospital, Inc. | 30 | 2011-04-01 | 2016-01-14 |
| Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation Analyze the pharmacokinetics of busulfan for transplantation - Acute Leukemia, Chronic Leukemia | Phase 2 / Phase 3 | Unknown | Hospital Israelita Albert Einstein | 100 | 2010-03-01 | 2014-12-03 |
| Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia Alemtuzumab, Fludarabine, Cytoxan - Leukemia, B-cell Leukemia | Phase 2 | Completed | Steven E. Coutre | 25 | 2004-07-01 | 2014-10-06 |
Myelodysplastic Syndromes (3) · Lymphoma (2) · Anemia, Aplastic (1) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Immunologic Deficiency Syndromes (1) · Leukemia (1) · Leukemia, B-Cell (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Multiple Myeloma (1) · Myeloproliferative Disorders (1) · Neoplasms, Plasma Cell (1) · Thrombocythemia, Essential (1)
Hematologic Diseases (6) · Hemic and Lymphatic Diseases (6) · Bone Marrow Diseases (5) · Immune System Diseases (5) · Immunoproliferative Disorders (5) · Lymphatic Diseases (5) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Hemorrhagic Disorders (2) · Anemia (1) · Blood Coagulation Disorders (1) · Blood Platelet Disorders (1) · Blood Protein Disorders (1) · Bone Marrow Failure Disorders (1)
Cyclophosphamide (2) · fludarabine (2) · fludarabine phosphate (2) · Alemtuzumab (1) · Busulfan (1) · Peripheral Blood Stem Cell Transplantation (1) · Transplantation (1) · ixazomib (1)
Northside Hospital, Inc. (2) · Hospital Israelita Albert Einstein (1) · Seoul National University Hospital (1) · Singapore General Hospital (1) · Steven E. Coutre (1)
United States (3) · Brazil (1) · Singapore (1) · South Korea (1)
Hyoung Jin Kang, MD., PhD (1) · Nelson Hamerschlak, Doctor (1) · Scott R Solomon, MD (1) · Steven Edward Coutre (1) · William YK Hwang, MBBS, FRCP (1)